This protocol is judged by an institutional critique board, an impartial group that opinions any medical trials involving individuals. If a study includes a Routine I drug, when the board approves the protocol as moral, the scientists have to make an application for an investigational new drug (IND) selection from the FDA.Access to unlawful medici